WO2014157007A1 - Cosmetic preparation for skin - Google Patents
Cosmetic preparation for skin Download PDFInfo
- Publication number
- WO2014157007A1 WO2014157007A1 PCT/JP2014/057894 JP2014057894W WO2014157007A1 WO 2014157007 A1 WO2014157007 A1 WO 2014157007A1 JP 2014057894 W JP2014057894 W JP 2014057894W WO 2014157007 A1 WO2014157007 A1 WO 2014157007A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- extract
- skin
- component
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Definitions
- the present invention relates to a skin cosmetic.
- the present invention has no foaming and uneven color at the time of application, in addition to no stickiness at the time of application and after application, can prevent discoloration of the skin cosmetics, and changes within a range in which the skin color does not feel strange immediately after application.
- An object of the present invention is to provide a skin cosmetic that has both the effect and the sustainability thereof and the long-term whitening effect.
- the skin cosmetic of the present invention as a means for solving the above-mentioned problems is (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate, (C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide, (D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract.
- the present invention it is possible to solve the above-described problems and achieve the above-mentioned object, there is no foaming and color unevenness at the time of application, and there is no stickiness at the time of application and after application. Discoloration can be prevented, and a skin cosmetic that combines the effect of changing the skin color within a range that does not feel uncomfortable immediately after application and the sustainability thereof, and the long-term whitening effect can be provided.
- the skin cosmetic of the present invention is coated with (A) at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) at least one of stearic acid and potassium stearate, and (C) coated with titanium oxide. At least one of mica coated with titanium oxide containing mica and tin oxide, (D) water-swellable clay mineral, and (E) alpinia katsudai seed extract, (F) mixed extract, It contains other components as necessary.
- the skin cosmetic of the present invention is emulsified using (A) at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol, and (B) at least one of stearic acid and potassium stearate.
- these components act synergistically, There is no foaming or uneven color at the time, in addition to the non-stickiness at the time of application and after application, the skin cosmetics can be prevented from discoloring, and the effect of changing the skin color within the range that does not feel strange immediately after application
- Cetyl alcohol, cetostearyl alcohol, stearyl alcohol As the component (A), at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol is used.
- the cetyl alcohol is a higher saturated aliphatic alcohol having 16 carbon atoms and is represented as CH 3 (CH 2 ) 15 OH. Also called cetanol or palmityl alcohol.
- the IUPAC system name is 1-hexadecanol.
- the stearyl alcohol is a higher saturated aliphatic alcohol having 18 carbon atoms and is represented as CH 3 (CH 2 ) 17 OH.
- the cetostearyl alcohol is a mixture of cetyl alcohol and stearyl alcohol, and is a mixture of a higher saturated aliphatic alcohol having 16 carbon atoms and a higher saturated aliphatic alcohol having 18 carbon atoms.
- the content of at least one selected from cetyl alcohol, cetostearyl alcohol, and stearyl alcohol as the component (A) is non-sticky after application, no color unevenness, and the total amount of the skin cosmetics, and From the standpoint of sustaining the effect of changing the skin color within a range that does not give a sense of incongruity, the content is 0.5% by mass to 15% by mass, and preferably 2% by mass to 10% by mass. If the content is less than 0.5% by mass, stickiness after application may occur, or the effect of changing the skin color within a range that does not give an uncomfortable feeling may not be sufficiently maintained. May cause unevenness.
- ⁇ (B) stearic acid, potassium stearate As the component (B), at least one of stearic acid and potassium stearate is used.
- the stearic acid is a saturated higher fatty acid and is represented by the molecular formula C 17 H 35 COOH.
- the IUPAC tissue name is octadecanoic acid.
- the potassium stearate is the potassium salt of stearic acid.
- the content of at least one of stearic acid and potassium stearate as the component (B) varies within a range in which foaming is suppressed, no stickiness after application, no stickiness after application, and skin color does not feel strange. From the standpoint of the durability of the effect and non-uniformity of the color, it is 0.5% by mass to 5% by mass and preferably 1.5% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic. If the content is less than 0.5% by mass, the stickiness is felt after coating, the sticking suppression effect over time after coating is not sufficiently obtained, or the effect of changing the skin color within a range in which the skin color does not feel strange does not last. In some cases, if it exceeds 5% by mass, foaming may occur during application or color unevenness may occur.
- the mica coated with the titanium oxide is not particularly limited, and a commercially available product can be used.
- Examples of the commercially available product include Timiron Super Gold (manufactured by Merck), Timiron Super Blue (manufactured by Merck), Timiron Super Red (Merck), Timiron Super Green (Merck), Timiron Super Sheen MP1001 (Merck), Timiron Super Sheen MP1005 (Merck), and so on. These may be used individually by 1 type and may use 2 or more types together.
- the mica coated with the titanium oxide containing tin oxide is not particularly limited, and a commercially available product can be used.
- a commercially available product examples include Ronafair Balance Gold (manufactured by Merck & Co., Inc.), Ronafair Balance Blue ( Merck), Ronafair Balance Red (Merck), and the like. These may be used individually by 1 type and may use 2 or more types together.
- the content of at least one of the mica coated with titanium oxide of the component (C) and the mica coated with titanium oxide containing tin oxide is an effect of changing the skin color within a range in which the skin color does not feel strange immediately after application, and From the point of non-uniformity of color, it is 0.5% by mass to 5% by mass and preferably 1% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic. If the content is less than 0.5% by mass, the effect of changing the skin color immediately after application within a range in which the skin color does not feel uncomfortable may not be sufficient. If the content exceeds 5% by mass, the range in which the skin color does not feel uncomfortable immediately after application. The effect of changing the color may be insufficient or color unevenness may occur.
- the water-swellable clay mineral of component (D) is not particularly limited and may be appropriately selected depending on the intended purpose.
- montmorillonite and hectorite are preferable from the viewpoint of non-stickiness with time after coating, and montmorillonite having a swelling power of 50 mL / 2 g or more is particularly preferable.
- the swelling power is determined according to the test method for the swelling power of bentonite according to the 15th revision Japanese Pharmacopoeia.
- the test method for the swelling power of bentonite is specifically as follows. -Test method for the swelling power of bentonite (15th revision Japanese Pharmacopoeia)- Take 2.0 g of measurement sample (bentonite) and add to a 100 mL graduated cylinder containing 100 mL of water in 10 portions. However, after the previously added measurement sample is almost deposited, the next measurement sample is added. When this is left for 24 hours, the apparent volume of the container lump is above the 20 mL scale. That is, in the test method, the swelling power of the montmorillonite can be obtained by the same method as the test method except that the measurement sample is changed from bentonite to montmorillonite.
- the water-swellable clay mineral (D) may be a natural product or a synthetic product. Commercial products can also be used. Examples of commercially available products of the component (D) include trade name Kunipia G (swelling power 50 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.), trade name Kunipia F (swelling power 45 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.).
- Montmorillonite such as trade name Bengel FW (swelling force 35 mL / 2 g, manufactured by HOJUN Co., Ltd.); saponite such as Smecton SA (produced by Kunimine Kogyo Co., Ltd.); Examples include hectorite such as light (manufactured by Kunimine Kogyo Co., Ltd.); steven site such as trade name Ionite T (manufactured by Mizusawa Chemical Co., Ltd.) Among the montmorillonites, when comparing Kunipia G and Kunipia F, Kunipia G having a swelling power of 50 mL / 2 g or more is more preferable. These may be used alone or in combination of two or more.
- the content of the water-swellable clay mineral of the component (D) is based on the non-stickiness with time after application and the sustainability of the effect of changing the skin color within a range in which the skin color does not feel strange,
- the content is 0.1% by mass to 10% by mass, and more preferably 0.2% by mass to 5% by mass. If the content is less than 0.1% by mass, the effect of changing the skin color within a range that does not cause a sense of incongruity may not be sufficient, and if it exceeds 10% by mass, it will feel sticky over time after application. There is.
- the (E) component Alpinia katsudai seed extract is a seed of Alpinia katsusumai Hayata extracted as it is or after pulverization with a solvent.
- the solvent for obtaining the Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, and isobutanol.
- Lower alcohol or hydrous lower alcohol propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3-pentane
- Polyhydric alcohol or hydrous polyhydric alcohol such as diol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, diol
- organic solvents such as ethanol, acetonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .
- acids eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc. adjusted to an appropriate degree
- the above-mentioned Alpinia katsudai seed extract can be further subjected to a refining operation after solvent extraction.
- the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism.
- an acid eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.
- alkali eg, sodium hydroxide, calcium hydroxide, ammonia, etc.
- the component (E) Commercially available products of the component (E) include, for example, the trade name Alpinia White (0.2% by mass as the pure extract of Alpinia katsudai seed extract, 69.9% by mass of 1,3-butylene glycol, and 29. 9% by mass, manufactured by Ichimaru Falcos Co., Ltd.).
- the content of the component (E) Alpinia katsudai seed extract is not particularly limited and may be appropriately selected depending on the intended purpose. From the viewpoint of long-term whitening effect and no discoloration of the cream, the content (E ′) is preferably 0.0002% by mass to 0.02% by mass, more preferably 0.001% by mass to 0.01% by mass. .
- a commercial item can be used, for example, brand name Plantage EX (0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract) 0.047% by mass as the pure content, 0.035% by mass as the pure extract of the Magwa root bark extract, 0.063% by mass as the pure extract of the jujube fruit extract, and 0.045% by mass as the pure extract of the Ogon extract 1,3-butylene glycol 79.405% by mass, and water 19.905% by mass, manufactured by Maruzen Pharmaceutical Co., Ltd.).
- Plantage EX 0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract
- the content of the component (F) is not particularly limited and may be appropriately selected depending on the intended purpose.
- a pure extract (F ′) of a mixed extract consisting of an extract and an argon extract 0.00069% by mass to 0.069% by mass is preferable. 0.00345% by mass to 0.0345% by mass is more preferable.
- the extraction solvent for obtaining each extract used in the present invention is not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include water, methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol, isobutanol and the like.
- Lower alcohol or water-containing lower alcohol propylene glycol, 1,3-butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol, 1,5-pentanediol, 1,2-pentanediol, 1,3- Polyhydric alcohols or hydrous polyhydric alcohols such as pentanediol, 1,4-pentanediol, 1,3,5-pentanetriol, glycerin, polyethylene glycol; acetone, ethyl acetate, diethyl ether, dimethyl ether, ethyl methyl ether, dioxane, A Various organic solvents such as tonitrile, xylene, benzene, chloroform, carbon tetrachloride, phenol, toluene, etc .; acids (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, formic acid, acetic acid, etc.) adjusted to appropriate standards
- Each extract used in the present invention can be further subjected to a refining operation after solvent extraction.
- the purification operation include decomposition by adding an acid (eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (eg, sodium hydroxide, calcium hydroxide, ammonia, etc.), fermentation or metabolism by a microorganism.
- an acid eg, hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.
- alkali eg, sodium hydroxide, calcium hydroxide, ammonia, etc.
- the skin cosmetic of the present invention can contain other components as necessary within a range not impairing the effects of the present invention.
- the other components are not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include nonionic surfactants, silicone oils, ester oils and other oils, silicone powders, polymer compounds, moisturizing agents. Agents, inclusion compounds, vitamins, UV absorbers, UV scattering agents, amino acids, anti-inflammatory agents, cooling agents, antioxidants, colorants, fragrances, preservatives, solvents (eg, ethanol, etc.), fatty acids , Water (for example, purified water, ion-exchanged water, etc.), pH adjuster, and the like.
- the content of the other components is not particularly limited and can be appropriately selected according to the purpose.
- the purified water of the other components, the humectant of the other components, methyl paraoxybenzoate, and potassium hydroxide were weighed in a vessel of a vacuum emulsification kettle.
- the polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state.
- the component (A), the stearic acid of the component (B), the component (C), the propyl paraoxybenzoate, the titanium oxide, the nonporous spherical silicone powder, the oil component as the other components And the nonionic surfactant were dissolved by heating to 70 ° C.
- a skin cosmetic can be produced by further cooling in minutes.
- the pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
- the purified water of the other components, the humectant of the other components, and methyl paraoxybenzoate and potassium hydroxide were weighed in a vacuum emulsification vessel vessel.
- the polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state.
- the oil and nonionic surfactant were dissolved by heating to 70 ° C.
- a skin cosmetic can be produced by further cooling in minutes.
- the pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
- the dosage form of the skin cosmetic of the present invention is not particularly limited, and can be appropriately selected according to the purpose.
- it can be selected as a liquid, cream, lotion, foam, gel, powder, Examples include emulsions and solids.
- the skin cosmetics of the present invention can be used for, for example, day creams (day creams, day creams), makeup bases, powder foundations, cream foundations, liquid foundations, and the like.
- Examples 1 to 47 and Comparative Examples 1 to 24 The skin cosmetics (day creams) of Examples 1 to 47 and Comparative Examples 1 to 24 having the compositions and contents shown in the following table are classified according to whether stearic acid or potassium stearate is used as the component (B). It was prepared as follows.
- component (B) ⁇ When stearic acid is used as component (B)> Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure.
- a humectant 1,3-butylene glycol, glycerin
- methyl paraoxybenzoate methyl paraoxybenzoate
- potassium hydroxide potassium hydroxide
- component (A) or component (A ′), stearic acid or component (B ′) of component (B), component (C), propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone The powder, other oil (cyclopentasiloxane), and nonionic surfactant (sorbitan monostearate, glyceryl tri (caprylic / capric)) were heated to 70 ° C. and dissolved. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure.
- (A) component, (B) component potassium stearate, (C) component, propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder, other oils (cyclopentasiloxane), And a nonionic surfactant (sorbitan monostearate, tri (caprylic acid / capric acid) glyceryl) were dissolved by heating to 70 ° C. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by adding citric acid.
- X Five or less persons judged that it was favorable.
- ⁇ E [ ⁇ (L value before application) ⁇ (L value after application) ⁇ 2 + ⁇ (a value before application) ⁇ (a value after application) ⁇ 2 + ⁇ (b value before application) ⁇ (B value after application) ⁇ 2 ] 1/2
- the average value of ⁇ E is preferably 1.5 or more and less than 9.0, and preferably 3.0 or more and 6. Less than 0 is more preferable. If the average value of ⁇ E is less than 1.5, the change in color may not be known, and if it is 9.0 or more, the color may change too much and feel uncomfortable.
- ⁇ Evaluation criteria Average value of ⁇ E is 0.0 or more and less than 1.5 ⁇ : Average value of ⁇ E is 1.5 or more and less than 3.0 ⁇ : Average value of ⁇ E is 3.0 or more and less than 6.0 ⁇ : Average of ⁇ E The value is 6.0 or more and less than 9.0 ⁇ : The average value of ⁇ E is 9.0 or more and less than 12.0 ⁇ : The average value of ⁇ E is 12.0 or more
- ⁇ E ′ [ ⁇ (L value after 5 minutes after application) ⁇ (L value after application and normal life for 4 hours) ⁇ 2 + ⁇ (a value after 5 minutes after application) -(A value after applying and living a normal life for 4 hours) ⁇ 2 + ⁇ (b value after applying and 5 minutes after application)-(after applying and living a normal life for 4 hours) b value) ⁇ 2 ] 1/2
- the average value of ⁇ E ′ is preferably 0.0 or more and less than 2.0. 0.0 or more and less than 1.0 is more preferable.
- ⁇ Long-term whitening effect> L-value measurement using a melanin-containing three-dimensional skin model in which human normal skin cells are layered with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.) The measurement was performed with a human Lab value measurement using a spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.).
- medium change every day serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF, trade names EPI-100LLM, MatTek
- medium change every day serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF, trade names EPI-100LLM, MatTek
- PBS phosphate buffered saline
- a melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 ⁇ g of PBS is applied to the skin in each cup.
- Samples are replaced every two days, medium is replaced every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, ⁇ -MSH, and ⁇ -FGF) (Trade name EPI-100LLM, manufactured by MatTek) and cultured at 37 ° C. for 15 days.
- EPI-100LLM Trade name EPI-100LLM, manufactured by MatTek
- the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), the L value was measured, and the ⁇ L value was calculated based on the following formula.
- ⁇ L (L value of cells coated with each sample ⁇ L value of cells coated with PBS used as a negative control) From the obtained average value of ⁇ L, long-term whitening effect was evaluated according to the following evaluation criteria.
- the average value of ⁇ L is preferably 20 or more, and more preferably 30 or more. If the average value of ⁇ L is less than 20, the long-term whitening effect may not be sufficient.
- ⁇ E ′′ [ ⁇ (L value before application) ⁇ (L value after one month) ⁇ 2 + ⁇ (a value before application) ⁇ (a value after one month) ⁇ 2 + ⁇ (b before application) Value) ⁇ (b value after one month) ⁇ 2 ] 1/2 From the obtained average value of ⁇ E ′′, long-term whitening effect was evaluated according to the following evaluation criteria.
- the average value of ⁇ E ′′ is preferably 1.0 or more, and more preferably 2.0 or more.
- the average value of ⁇ E ′′ is 2.0 or more ⁇ : The average value of ⁇ E ′′ is 1.0 or more and less than 2.0 ⁇ : The average value of ⁇ E ′′ is 0.5 or more and less than 1.0 ⁇ : The average of ⁇ E ′′ Value less than 0.5
- the skin cosmetic of the present invention can be suitably used for, for example, day cream (daytime cream, daytime cream), makeup base, powder foundation, cream foundation, liquid foundation and the like.
- Examples of the aspect of the present invention include the following. ⁇ 1> (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate, (C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide, (D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract, It is a skin cosmetic characterized by containing.
- the skin cosmetic according to ⁇ 1> further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
- a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
- the content of the component (E) alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract, according to any one of ⁇ 1> to ⁇ 2> above It is a skin cosmetic.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
前記塗布した直後から肌色を違和感のない範囲内で変化させる効果を有する技術としては、例えば、酸化チタン被覆マイカを含む皮膚化粧料(特許文献1、2及び3参照)、酸化チタン被覆マイカの周りに更に酸化鉄(ベンガラ)を被覆したものを含み、肌色を変えることができる皮膚化粧料(特許文献4参照)、などが提案されている。
一方、美白成分としては、例えば、アルブチン、コウジ酸、エラグ酸、などが知られている。 In Japan, Indonesia and other Asian countries where the sun is strong, the functions required for day cream are not sticky after application and not sticky over time after application. It has the effect of changing within a range that is not present, and has a high whitening effect when used for a long time.
Examples of the technology having an effect of changing the skin color within a range in which there is no sense of incongruity immediately after the application include, for example, skin cosmetics containing titanium oxide-coated mica (see Patent Documents 1, 2, and 3), Furthermore, skin cosmetics (see Patent Document 4) that can change the skin color, including those coated with iron oxide (Bengara), have been proposed.
On the other hand, as whitening components, for example, arbutin, kojic acid, ellagic acid and the like are known.
(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
(D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
(E)アルピニアカツマダイ種子エキス、を含有する。 The skin cosmetic of the present invention as a means for solving the above-mentioned problems is (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol,
(B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
(C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
(D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract.
本発明の皮膚化粧料は、(A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種、(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれか、(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれか、(D)水膨潤性粘土鉱物、並びに(E)アルピニアカツマダイ種子エキス、を含有し、(F)混合エキス、更に必要に応じてその他の成分を含有してなる。 (Skin cosmetic)
The skin cosmetic of the present invention is coated with (A) at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol, (B) at least one of stearic acid and potassium stearate, and (C) coated with titanium oxide. At least one of mica coated with titanium oxide containing mica and tin oxide, (D) water-swellable clay mineral, and (E) alpinia katsudai seed extract, (F) mixed extract, It contains other components as necessary.
前記(A)成分としては、セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種が用いられる。
前記セチルアルコールは、炭素数16の高級飽和脂肪族アルコールであり、CH3(CH2)15OHと表される。セタノール、パルミチルアルコールとも呼ばれる。IUPAC系統名は1-ヘキサデカノールである。
前記ステアリルアルコールは、炭素数18の高級飽和脂肪族アルコールであり、CH3(CH2)17OHと表される。
前記セトステアリルアルコールは、セチルアルコールとステアリルアルコールの混合物であり、炭素数16の高級飽和脂肪族アルコールと炭素数18の高級飽和脂肪族アルコールとの混合物である。 <(A) Cetyl alcohol, cetostearyl alcohol, stearyl alcohol>
As the component (A), at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol is used.
The cetyl alcohol is a higher saturated aliphatic alcohol having 16 carbon atoms and is represented as CH 3 (CH 2 ) 15 OH. Also called cetanol or palmityl alcohol. The IUPAC system name is 1-hexadecanol.
The stearyl alcohol is a higher saturated aliphatic alcohol having 18 carbon atoms and is represented as CH 3 (CH 2 ) 17 OH.
The cetostearyl alcohol is a mixture of cetyl alcohol and stearyl alcohol, and is a mixture of a higher saturated aliphatic alcohol having 16 carbon atoms and a higher saturated aliphatic alcohol having 18 carbon atoms.
前記(B)成分としては、ステアリン酸及びステアリン酸カリウムの少なくともいずれかが用いられる。
前記ステアリン酸は、飽和高級脂肪酸であり、分子式C17H35COOHで表される。IUPAC組織名はオクタデカン酸である。
前記ステアリン酸カリウムは、前記ステアリン酸のカリウム塩である。 <(B) stearic acid, potassium stearate>
As the component (B), at least one of stearic acid and potassium stearate is used.
The stearic acid is a saturated higher fatty acid and is represented by the molecular formula C 17 H 35 COOH. The IUPAC tissue name is octadecanoic acid.
The potassium stearate is the potassium salt of stearic acid.
前記含有量が、0.5質量%未満であると、塗布後にべたつきを感じたり、塗布後経時のべたつき抑制効果が十分に得られなかったり、肌色を違和感ない範囲内で変化させる効果が持続しないことがあり、5質量%を超えると、塗布時に泡立ちを生じたり、色むらを生じることがある。 The content of at least one of stearic acid and potassium stearate as the component (B) varies within a range in which foaming is suppressed, no stickiness after application, no stickiness after application, and skin color does not feel strange. From the standpoint of the durability of the effect and non-uniformity of the color, it is 0.5% by mass to 5% by mass and preferably 1.5% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic.
If the content is less than 0.5% by mass, the stickiness is felt after coating, the sticking suppression effect over time after coating is not sufficiently obtained, or the effect of changing the skin color within a range in which the skin color does not feel strange does not last. In some cases, if it exceeds 5% by mass, foaming may occur during application or color unevenness may occur.
前記(C)成分としては、酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかが用いられる。 <(C) Mica coated with titanium oxide, mica coated with titanium oxide containing tin oxide>
As the component (C), at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide is used.
前記含有量が、0.5質量%未満であると、塗布直後から肌色を違和感ない範囲内で変化させる効果が十分でないことがあり、5質量%を超えると、塗布直後から肌色を違和感ない範囲内で変化させる効果が不十分となったり、色むらが生じることがある。 The content of at least one of the mica coated with titanium oxide of the component (C) and the mica coated with titanium oxide containing tin oxide is an effect of changing the skin color within a range in which the skin color does not feel strange immediately after application, and From the point of non-uniformity of color, it is 0.5% by mass to 5% by mass and preferably 1% by mass to 4.5% by mass with respect to the total amount of the skin cosmetic.
If the content is less than 0.5% by mass, the effect of changing the skin color immediately after application within a range in which the skin color does not feel uncomfortable may not be sufficient. If the content exceeds 5% by mass, the range in which the skin color does not feel uncomfortable immediately after application. The effect of changing the color may be insufficient or color unevenness may occur.
前記(D)成分の水膨潤性粘土鉱物としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ベントナイト、モンモリロナイト、バイデライト、ノントロナイト、サポナイト、ソーコナイト、ヘクトライト、スチブンサイト、などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、塗布後経時のべたつきのなさの点で、モンモリロナイト、ヘクトライトが好ましく、膨潤力が50mL/2g以上であるモンモリロナイトが特に好ましい。 <(D) Water-swellable clay mineral>
The water-swellable clay mineral of component (D) is not particularly limited and may be appropriately selected depending on the intended purpose. For example, bentonite, montmorillonite, beidellite, nontronite, saponite, sauconite, hectorite, stevensite , Etc. These may be used alone or in combination of two or more. Among these, montmorillonite and hectorite are preferable from the viewpoint of non-stickiness with time after coating, and montmorillonite having a swelling power of 50 mL / 2 g or more is particularly preferable.
-ベントナイトの膨潤力の試験方法(第十五改正日本薬局方)-
測定試料(ベントナイト)2.0gをとり、水100mLを入れた100mLメスシリンダーに10回に分けて加える。ただし、先に加えた前記測定試料がほとんど沈着した後、次の測定試料を加える。これを24時間放置するとき、容器の塊の見かけの容積は20mLの目盛り以上である。即ち、前記試験方法において、測定試料を、ベントナイトからモンモリロナイトに代える以外は、前記試験方法と同様の方法で、該モンモリロナイトの膨潤力を求めることができる。 The swelling power is determined according to the test method for the swelling power of bentonite according to the 15th revision Japanese Pharmacopoeia. The test method for the swelling power of bentonite is specifically as follows.
-Test method for the swelling power of bentonite (15th revision Japanese Pharmacopoeia)-
Take 2.0 g of measurement sample (bentonite) and add to a 100 mL graduated cylinder containing 100 mL of water in 10 portions. However, after the previously added measurement sample is almost deposited, the next measurement sample is added. When this is left for 24 hours, the apparent volume of the container lump is above the 20 mL scale. That is, in the test method, the swelling power of the montmorillonite can be obtained by the same method as the test method except that the measurement sample is changed from bentonite to montmorillonite.
前記(D)成分の市販品としては、例えば、商品名クニピアG(膨潤力50mL/2g以上、クニミネ工業株式会社製)、商品名クニピアF(膨潤力45mL/2g以上、クニミネ工業株式会社製)、商品名ベンゲルFW(膨潤力35mL/2g、HOJUN株式会社製)等のモンモリロナイト;商品名スメクトンSA(クニミネ工業株式会社製)等のサポナイト;商品名HECTABRITE(株式会社ボルクレイ・ジャパン製)、合成ヘクトライト(クニミネ工業株式会社製)等のヘクトライト;商品名イオナイトT(水澤化学工業株式会社製)等のスチブンサイト、などが挙げられる。前記モンモリロナイトの中でも、クニピアGとクニピアFを比べると、膨潤力が50mL/2g以上であるクニピアGの方がより好ましい。これらは、1種単独で使用してもよく、2種以上を併用してもよい。 The water-swellable clay mineral (D) may be a natural product or a synthetic product. Commercial products can also be used.
Examples of commercially available products of the component (D) include trade name Kunipia G (swelling power 50 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.), trade name Kunipia F (swelling power 45 mL / 2 g or more, manufactured by Kunimine Industries Co., Ltd.). Montmorillonite such as trade name Bengel FW (swelling force 35 mL / 2 g, manufactured by HOJUN Co., Ltd.); saponite such as Smecton SA (produced by Kunimine Kogyo Co., Ltd.); Examples include hectorite such as light (manufactured by Kunimine Kogyo Co., Ltd.); steven site such as trade name Ionite T (manufactured by Mizusawa Chemical Co., Ltd.) Among the montmorillonites, when comparing Kunipia G and Kunipia F, Kunipia G having a swelling power of 50 mL / 2 g or more is more preferable. These may be used alone or in combination of two or more.
前記(E)成分のアルピニアカツマダイ種子エキスは、ショウガ科アルピニアカツマダイ(Alpinia katsumadai Hayata)の種子を、そのままあるいは粉砕後、溶媒で抽出したものである。 <(E) Alpinia katsudai seed extract>
The (E) component Alpinia katsudai seed extract is a seed of Alpinia katsusumai Hayata extracted as it is or after pulverization with a solvent.
前記(F)成分の混合エキスとしては、特に制限はなく、市販品を用いることができ、例えば、商品名プランテージEX(カンゾウ根エキスのエキス純分として0.5質量%、カワラヨモギエキスのエキス純分として0.047質量%、マグワ根皮エキスのエキス純分として0.035質量%、ナツメ果実エキスのエキス純分として0.063質量%、オウゴンエキスのエキス純分として0.045質量%、1,3-ブチレングリコール79.405質量%、及び水19.905質量%、丸善製薬株式会社製)、などが挙げられる。 <(F) Mixed extract consisting of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and gourd extract>
There is no restriction | limiting in particular as a mixed extract of said (F) component, A commercial item can be used, for example, brand name Plantage EX (0.5 mass% as a pure extract of a licorice root extract, an extract of Kawamomogi extract) 0.047% by mass as the pure content, 0.035% by mass as the pure extract of the Magwa root bark extract, 0.063% by mass as the pure extract of the jujube fruit extract, and 0.045% by mass as the pure extract of the Ogon extract 1,3-butylene glycol 79.405% by mass, and water 19.905% by mass, manufactured by Maruzen Pharmaceutical Co., Ltd.).
本発明の皮膚化粧料は、本発明の効果を損なわない範囲で、必要に応じてその他の成分を含有することができる。
前記その他の成分としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、非イオン性界面活性剤、シリコーン油、エステル油等の油分、シリコーン粉体、高分子化合物、保湿剤、包接化合物、ビタミン類、紫外線吸収剤、紫外線散乱剤、アミノ酸類、抗炎症剤、冷感付与剤、酸化防止剤、着色剤、香料、防腐剤、溶剤(例えば、エタノール等)、脂肪酸、水(例えば、精製水、イオン交換水等)、pH調整剤、などが挙げられる。前記その他の成分の含有量は、特に制限はなく、目的に応じて適宜選定することができる。 <Other ingredients>
The skin cosmetic of the present invention can contain other components as necessary within a range not impairing the effects of the present invention.
The other components are not particularly limited and may be appropriately selected depending on the intended purpose. Examples thereof include nonionic surfactants, silicone oils, ester oils and other oils, silicone powders, polymer compounds, moisturizing agents. Agents, inclusion compounds, vitamins, UV absorbers, UV scattering agents, amino acids, anti-inflammatory agents, cooling agents, antioxidants, colorants, fragrances, preservatives, solvents (eg, ethanol, etc.), fatty acids , Water (for example, purified water, ion-exchanged water, etc.), pH adjuster, and the like. The content of the other components is not particularly limited and can be appropriately selected according to the purpose.
前記皮膚化粧料の製造方法としては、特に制限はなく、目的に応じて適宜選択することができるが、前記(B)成分としてステアリン酸を用いる場合と、ステアリン酸カリウムを用いる場合とで異なるので、以下に分けて説明する。 <Manufacturing method>
There is no restriction | limiting in particular as a manufacturing method of the said skin cosmetics, Although it can select suitably according to the objective, Since it differs by the case where a stearic acid is used as said (B) component and the case where potassium stearate is used, it is different. This will be described separately below.
前記その他の成分の精製水、前記その他の成分の保湿剤、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた前記その他の成分の高分子化合物を添加し、減圧状態で、70℃に加温した。別のビーカーにて、前記(A)成分、前記(B)成分のステアリン酸、前記(C)成分、前記その他の成分としてのパラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、油分、及び非イオン性界面活性剤を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却する。冷却後、前記(D)成分、前記(E)成分、必要に応じて前記(F)成分、前記その他の成分としての香料、及び残りの前記その他の成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、皮膚化粧料を製造することができる。なお、pHは25℃の条件下、pHメーター(例えば、TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整することができる。 -When stearic acid is used as component (B)-
The purified water of the other components, the humectant of the other components, methyl paraoxybenzoate, and potassium hydroxide were weighed in a vessel of a vacuum emulsification kettle. The polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state. In a separate beaker, the component (A), the stearic acid of the component (B), the component (C), the propyl paraoxybenzoate, the titanium oxide, the nonporous spherical silicone powder, the oil component as the other components And the nonionic surfactant were dissolved by heating to 70 ° C. After dissolution, while stirring the paddle, the dissolved oil and the like are added to the vessel and stirred, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, the component (D), the component (E), the component (F), the fragrance as the other component, and the remaining other components as necessary, are added, A skin cosmetic can be produced by further cooling in minutes. The pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
前記その他の成分の精製水、前記その他の成分の保湿剤、及びパラオキシ安息香酸メチル及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた前記その他の成分の高分子化合物を添加し、減圧状態で、70℃に加温した。別のビーカーにて、前記(A)成分、前記(B)成分のステアリン酸カリウム、前記(C)成分、前記その他の成分としてのパラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、油分、及び非イオン性界面活性剤を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却する。冷却後、前記(D)成分、前記(E)成分、必要に応じて前記(F)成分、前記その他の成分としての香料、及び残りの前記その他の成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、皮膚化粧料を製造することができる。なお、pHは25℃の条件下、pHメーター(例えば、TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整することができる。 -When potassium stearate is used as component (B)-
The purified water of the other components, the humectant of the other components, and methyl paraoxybenzoate and potassium hydroxide were weighed in a vacuum emulsification vessel vessel. The polymer compound of the said other component swollen with purified water was added there, and it heated at 70 degreeC in the pressure reduction state. In a separate beaker, the component (A), the potassium stearate of the component (B), the component (C), the propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder as the other components, The oil and nonionic surfactant were dissolved by heating to 70 ° C. After dissolution, while stirring the paddle, the dissolved oil and the like are added to the vessel and stirred, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, the component (D), the component (E), the component (F), the fragrance as the other component, and the remaining other components as necessary, are added, A skin cosmetic can be produced by further cooling in minutes. The pH is measured with a pH meter (for example, HM-30G, manufactured by TOA-DKK Co., Ltd.) at 25 ° C., and can be adjusted to pH 7.0 by adding citric acid.
本発明の皮膚化粧料の剤型としては、特に制限されるものではなく、目的に応じて適宜選択することができ、例えば、液状、クリーム状、ローション状、泡状、ジェル状、パウダー状、乳液状、固形状、などが挙げられる。 -Dosage form-
The dosage form of the skin cosmetic of the present invention is not particularly limited, and can be appropriately selected according to the purpose. For example, it can be selected as a liquid, cream, lotion, foam, gel, powder, Examples include emulsions and solids.
本発明の皮膚化粧料は、例えば、デイクリーム(昼用クリーム、日中用クリーム)、化粧下地、パウダーファンデーション、クリームファンデーション、リキッドファンデーション、などに用いることができる。 -Applications-
The skin cosmetics of the present invention can be used for, for example, day creams (day creams, day creams), makeup bases, powder foundations, cream foundations, liquid foundations, and the like.
下記表に示す組成及び含有量の実施例1~47及び比較例1~24の皮膚化粧料(デイクリーム)を、(B)成分としてステアリン酸を用いるか、ステアリン酸カリウムを用いるかにより分けて、以下のようにして調製した。 (Examples 1 to 47 and Comparative Examples 1 to 24)
The skin cosmetics (day creams) of Examples 1 to 47 and Comparative Examples 1 to 24 having the compositions and contents shown in the following table are classified according to whether stearic acid or potassium stearate is used as the component (B). It was prepared as follows.
下記表に従って、精製水、保湿剤(1,3-ブチレングリコール、グリセリン)、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた高分子化合物(カルボキシビニルポリマー)を添加し、減圧状態で、70℃に加温した。別のビーカーにて、(A)成分又は(A’)成分、前記(B)成分のステアリン酸又は(B’)成分、(C)成分、パラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、その他の油分(シクロペンタシロキサン)、及び非イオン性界面活性剤(モノステアリン酸ソルビタン、トリ(カプリル酸/カプリン酸)グリセリル)を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却した。冷却後、(D)成分、(E)成分、必要に応じて(F)成分、及び残りの共通成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、デイクリーム(皮膚化粧料)を製造した。なお、pHは25℃の条件下、pHメーター(TOA-DKK株式会社製、HM-30G)で測定し、水酸化カリウムの配合によってpH7.0に調整した。 <When stearic acid is used as component (B)>
Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure. In another beaker, component (A) or component (A ′), stearic acid or component (B ′) of component (B), component (C), propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone The powder, other oil (cyclopentasiloxane), and nonionic surfactant (sorbitan monostearate, glyceryl tri (caprylic / capric)) were heated to 70 ° C. and dissolved. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by blending with potassium hydroxide.
下記表に従って、精製水、保湿剤(1,3-ブチレングリコール、グリセリン)、パラオキシ安息香酸メチル、及び水酸化カリウムを真空乳化釜のベッセルに秤取した。そこに精製水で膨潤させた高分子化合物(カルボキシビニルポリマー)を添加し、減圧状態で、70℃に加温した。別のビーカーにて、(A)成分、(B)成分のステアリン酸カリウム、(C)成分、パラオキシ安息香酸プロピル、酸化チタン、無孔質球状シリコーン粉体、その他の油分(シクロペンタシロキサン)、及び非イオン性界面活性剤(モノステアリン酸ソルビタン、トリ(カプリル酸/カプリン酸)グリセリル)を、70℃に加温して溶解した。溶解後、パドルを攪拌しながら、溶解した油分等をベッセル内に添加し攪拌した後、減圧状態で1℃/分間で35℃まで冷却した。冷却後、(D)成分、(E)成分、必要に応じて(F)成分、及び残りの共通成分を添加し、25℃まで1℃/分間で更に冷却を行うことで、デイクリーム(皮膚化粧料)を製造した。なお、pHは25℃の条件下、pHメーター(TOA-DKK株式会社製、HM-30G)で測定し、クエン酸の配合によってpH7.0に調整した。 <When using potassium stearate as component (B)>
Purified water, a humectant (1,3-butylene glycol, glycerin), methyl paraoxybenzoate, and potassium hydroxide were weighed in a vacuum emulsification vessel vessel according to the following table. A polymer compound (carboxyvinyl polymer) swollen with purified water was added thereto and heated to 70 ° C. under reduced pressure. In a separate beaker, (A) component, (B) component potassium stearate, (C) component, propyl paraoxybenzoate, titanium oxide, nonporous spherical silicone powder, other oils (cyclopentasiloxane), And a nonionic surfactant (sorbitan monostearate, tri (caprylic acid / capric acid) glyceryl) were dissolved by heating to 70 ° C. After dissolution, the dissolved oil and the like were added to the vessel while stirring the paddle, and then cooled to 35 ° C. at 1 ° C./min under reduced pressure. After cooling, add (D) component, (E) component, (F) component and the remaining common components as necessary, and further cool to 25 ° C. at 1 ° C./min. Cosmetics) were manufactured. The pH was measured with a pH meter (manufactured by TOA-DKK, HM-30G) at 25 ° C., and adjusted to pH 7.0 by adding citric acid.
また、「クリームの変色のなさ」、「肌色を違和感ない範囲内で変化させる効果(肌の色味変化)の持続性」、及び「長期的な美白効果」について、以下のようにして評価した。結果を表1~表15に示した。 Next, for each skin cosmetic (day cream) produced, “no foaming at the time of application”, “no stickiness after application”, “no stickiness over time after application”, “within the range where the skin color does not feel strange "Effects of changing skin tone (changes in skin color)" and "Non-color irregularity" for 20 male and female panelists (10 males, 10 females, 20 to 40 years old) After washing with 1 g of the form “Plant Monogatari” (manufactured by Lion Corporation) and towel drying, 0.5 mL of each skin cosmetic was taken on the palm and spread on the face. For each evaluation item, sensory evaluation was performed based on the following criteria. The results are shown in Tables 1 to 15.
In addition, “no discoloration of the cream”, “sustainability of the effect of changing the skin color within a range that does not feel strange (skin color change)”, and “long-term whitening effect” were evaluated as follows. . The results are shown in Tables 1 to 15.
男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)により、「塗布時の泡立ちのなさ」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
○:10名以上13名以下が良好と判断した。
△:6名以上9名以下が良好と判断した。
×:5名以下が良好と判断した。 <No foaming during application (evaluation during application)>
“No foaming at the time of application” was evaluated by 20 male and female panelists (10 males, 10 females, 20 to 40 years of age), and the following evaluation criteria were shown according to the number of respondents who answered that they were good.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
各皮膚化粧料を60℃に1ヶ月保存し、対照として-5℃に1ヶ月保存した各皮膚化粧料と比較し、「クリームの変色のなさ」を女性専門パネラー1名により評価した。
なお、「クリームの変色のなさ」とは、60℃で1ヶ月保存品について、-5℃で1ヶ月保存品と比較し、クリームの変色が認められないことを意味する。
〔評価基準〕
○:変色が認められなかった。
×:変色が認められた。 <No discoloration of skin cosmetics (cream)>
Each skin cosmetic was stored at 60 ° C. for 1 month, and compared with each skin cosmetic stored at −5 ° C. for 1 month as a control, “no discoloration of cream” was evaluated by one female panelist.
“No discoloration of the cream” means that the product stored at 60 ° C. for 1 month is not observed to be discolored compared to the product stored at −5 ° C. for 1 month.
〔Evaluation criteria〕
○: No discoloration was observed.
X: Discoloration was recognized.
男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)について、「塗布後のべたつきのなさ」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
○:10名以上13名以下が良好と判断した。
△:6名以上9名以下が良好と判断した。
×:5名以下が良好と判断した。 <No stickiness after application>
Twenty male and female panelists (10 males, 10 females, 20 to 40 years of age) were evaluated for “non-stickiness after application” and indicated by the following evaluation criteria according to the number of respondents who answered that they were good.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)について、「塗布後経時のべたつきのなさ(塗布し、4時間後に評価)」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
○:10名以上13名以下が良好と判断した。
△:6名以上9名以下が良好と判断した。
×:5名以下が良好と判断した。 <No stickiness over time after application>
Number of respondents who evaluated 20 men and women specialized panelists (10 men, 10 women, 20 to 40 years of age) on “no stickiness over time after application (applied and evaluated after 4 hours)” Based on the following evaluation criteria.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)において、「色むらのなさ(塗布し、5分間後に評価)」について評価し、良好と回答した人数により下記評価基準で示した。
〔評価基準〕
◎:18名以上が良好と判断した。
◎~○:14名以上17名以下が良好と判断した。
○:10名以上13名以下が良好と判断した。
△:6名以上9名以下が良好と判断した。
×:5名以下が良好と判断した。 <No color irregularity (apply and evaluate after 5 minutes)>
20 male and female panelists (10 males, 10 females, 20 to 40 years old) evaluated “no color irregularity (applied and evaluated after 5 minutes)”, and evaluated according to the number of respondents who answered that they were good Shown by criteria.
〔Evaluation criteria〕
A: 18 or more people judged good.
A to B: 14 to 17 people judged good.
○: 10 or more and 13 or less were judged good.
Δ: 6 or more and 9 or less were judged to be good.
X: Five or less persons judged that it was favorable.
塗布直後から肌色を違和感ない範囲内で変化させる効果については、簡易型分光色差計(NF333、日本電飾工業株式会社製)にてLab値の測定を行った。
Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定した。そして、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げ、塗布し、5分間後に再度Lab値を測定し、下記計算式に基づきΔEを算出し、20名の専門パネラーのΔEの平均値を求めた。
ΔE=[{(塗布前のL値)-(塗布後のL値)}2+{(塗布前のa値)-(塗布後のa値)}2+{(塗布前のb値)-(塗布後のb値)}2]1/2
なお、肌色を違和感ない範囲内で変化させる効果としては、適度な色味の変化において嗜好性が高く、ΔEの平均値は、1.5以上9.0未満が好ましく、3.0以上6.0未満がより好ましい。前記ΔEの平均値が、1.5未満であると、色味の変化がわからないことがあり、9.0以上であると、色味が変化しすぎて違和感を感じることがある。
求めたΔEの平均値から、以下の評価基準により、塗布直後から肌色を違和感ない範囲内で変化させる効果(肌の色味変化)について評価した。
〔評価基準〕
△:ΔEの平均値が0.0以上1.5未満
○:ΔEの平均値が1.5以上3.0未満
◎:ΔEの平均値が3.0以上6.0未満
○:ΔEの平均値が6.0以上9.0未満
△:ΔEの平均値が9.0以上12.0未満
×:ΔEの平均値が12.0以上 <Effect of changing skin color within a range that does not feel strange (skin color change) (applied and evaluated after 5 minutes)>
The Lab value was measured with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Kogyo Co., Ltd.) for the effect of changing the skin color within a range in which the skin color does not feel strange immediately after application.
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face-washing form “Plant Monogatari” (manufactured by Lion Corporation), towel-dried, and after 5 minutes, the Lab value was measured. Then, take 0.5 mL of each skin cosmetic on the palm, spread and apply to the face, measure the Lab value again after 5 minutes, calculate ΔE based on the following formula, and calculate ΔE of 20 professional panelists The average value was obtained.
ΔE = [{(L value before application) − (L value after application)} 2 + {(a value before application) − (a value after application)} 2 + {(b value before application) − (B value after application)} 2 ] 1/2
In addition, as an effect of changing the skin color within a range that does not give a sense of incongruity, palatability is high in an appropriate color change, and the average value of ΔE is preferably 1.5 or more and less than 9.0, and preferably 3.0 or more and 6. Less than 0 is more preferable. If the average value of ΔE is less than 1.5, the change in color may not be known, and if it is 9.0 or more, the color may change too much and feel uncomfortable.
From the obtained average value of ΔE, the following evaluation criteria were used to evaluate the effect of changing the skin color immediately after application within a range where there is no sense of incongruity (skin color change).
〔Evaluation criteria〕
Δ: Average value of ΔE is 0.0 or more and less than 1.5 ○: Average value of ΔE is 1.5 or more and less than 3.0 ◎: Average value of ΔE is 3.0 or more and less than 6.0 ○: Average of ΔE The value is 6.0 or more and less than 9.0 Δ: The average value of ΔE is 9.0 or more and less than 12.0 ×: The average value of ΔE is 12.0 or more
肌色を違和感ない範囲内で変化させる効果の持続性については、簡易型分光色差計(NF333、日本電色工業株式会社製)にてLab値の測定を行った。
Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げた。塗布し、5分間後、Lab値を測定し4時間通常通りの生活を送った。その後、再度Lab値を測定し、下記計算式に基づきΔE’を算出し、20名の専門パネラーのΔE’の平均値を求めた。
ΔE’=[{(塗布し、5分間後のL値)-(塗布し、4時間通常通りの生活を送った後のL値)}2+{(塗布し、5分間後のa値)-(塗布し、4時間通常通りの生活を送った後のa値)}2+{(塗布し、5分間後のb値)-(塗布し、4時間通常通りの生活を送った後のb値)}2]1/2
なお、肌色を違和感ない範囲内で変化させる効果の持続性については、色味の変化が少ないほうが嗜好性が高く、前記ΔE’の平均値は、0.0以上2.0未満が好ましく、0.0以上1.0未満がより好ましい。前記ΔE’の平均値が、2.0以上であると、色味が変化しすぎて肌色変化の持続性効果が十分ではないことがある。
求めたΔE’の平均値から、以下の評価基準により、肌色を違和感ない範囲内で変化させる効果(肌の色味変化)の持続性について評価した。
〔評価基準〕
◎:ΔE’の平均値が0.0以上1.0未満
○:ΔE’の平均値が1.0以上2.0未満
△:ΔE’の平均値が2.0以上3.0未満
×:ΔE’の平均値が3.0以上 <Sustainability of the effect of changing the skin color within a range that does not feel strange (skin color change)>
About the sustainability of the effect which changes skin color within the range which does not feel strange, the Lab value was measured with the simple spectral color difference meter (NF333, Nippon Denshoku Industries Co., Ltd.).
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face washing form “Plant Monogatari” (manufactured by Lion Corporation) and towel-dried, and then 0.5 mL of each skin cosmetic was taken on the palm and spread on the face. After application, 5 minutes later, the Lab value was measured and the normal life was spent for 4 hours. Thereafter, the Lab value was measured again, ΔE ′ was calculated based on the following formula, and the average value of ΔE ′ of 20 professional panelists was obtained.
ΔE ′ = [{(L value after 5 minutes after application) − (L value after application and normal life for 4 hours)} 2 + {(a value after 5 minutes after application) -(A value after applying and living a normal life for 4 hours)} 2 + {(b value after applying and 5 minutes after application)-(after applying and living a normal life for 4 hours) b value)} 2 ] 1/2
In addition, regarding the persistence of the effect of changing the skin color within a range in which the skin color does not feel uncomfortable, the smaller the change in color, the higher the preference, and the average value of ΔE ′ is preferably 0.0 or more and less than 2.0. 0.0 or more and less than 1.0 is more preferable. If the average value of ΔE ′ is 2.0 or more, the color may change too much and the sustaining effect of the skin color change may not be sufficient.
From the obtained average value of ΔE ′, the following evaluation criteria were used to evaluate the sustainability of the effect of changing the skin color within a range in which the skin color does not feel uncomfortable (skin color change).
〔Evaluation criteria〕
A: Average value of ΔE ′ is 0.0 or more and less than 1.0 ○: Average value of ΔE ′ is 1.0 or more and less than 2.0 Δ: Average value of ΔE ′ is 2.0 or more and less than 3.0 ×: The average value of ΔE 'is 3.0 or more
長期的な美白効果については、簡易型分光色差計(NF333、日本電色工業株式会社製)にてヒト正常皮膚細胞を重層培養したメラニン含有三次元皮膚モデルを用いたL値測定と、簡易型分光色差計(NF333、日本電色工業株式会社製)にてヒトでのLab値測定とで行った。
<<(1)ヒト正常皮膚細胞を重層培養したメラニン含有三次元皮膚モデルを用いた長期的な美白効果>>
メラニン含有三次元皮膚モデル(商品名MEL-312-A、MatTek社製、メラニン含有3次元皮膚、Asian donor)を37℃で15時間インキュベートし、その後、各カップ内の皮膚に評価クリームを100μgずつ塗り、2日間ごとに培地を用いてクリームを洗い流し、新たに評価クリームを100μgずつ塗る工程を繰り返した。更に1日間ごとに培地交換(無血清培地、hEGF、ハイドロコーチゾン等増殖因子、ゲンタマイシンアンフォテリシンB、α-MSH、及びβ-FGFを含有している培地、商品名EPI-100LLM、MatTek社製)を行い、15日間37℃にて培養を行った。
16日目に、PBS(Phosphate Buffered Saline)に溶解した10質量%ホルマリンを用いて皮膚を固定してL値を測定した。
また、メラニン含有三次元皮膚モデル(商品名MEL-312-A、MatTek社製、メラニン含有3次元皮膚、Asian donor)を37℃で15時間インキュベートし、その後、各カップ内の皮膚にPBSを100μgずつ入れ、2日間ごとにサンプル交換、1日間ごとに培地交換(無血清培地、hEGF、ハイドロコーチゾン等増殖因子、ゲンタマイシンアンフォテリシンB、α-MSH、及びβ-FGFを含有している培地、商品名EPI-100LLM、MatTek社製)を行い、15日間37℃にて培養を行った。
16日目に、PBS(Phosphate Buffered Saline)に溶解した10質量%ホルマリンを用いて皮膚を固定してL値を測定し、下記計算式に基づきΔL値を算出した。
ΔL=(各サンプルを塗布した細胞のL値-ネガティブコントロールとして用いたPBSを塗布した細胞のL値)
求めたΔLの平均値から、以下の評価基準により長期的な美白効果について評価した。
なお、前記ΔLの平均値は、20以上が好ましく、30以上がより好ましい。前記ΔLの平均値が、20未満であると、長期的な美白効果が十分ではないことがある。
〔評価基準〕
◎:ΔLの平均値が30以上
○:ΔLの平均値が20以上30未満
△:ΔLの平均値が10以上20未満
×:ΔLの平均値が10未満 <Long-term whitening effect>
For the long-term whitening effect, L-value measurement using a melanin-containing three-dimensional skin model in which human normal skin cells are layered with a simple spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.) The measurement was performed with a human Lab value measurement using a spectral color difference meter (NF333, manufactured by Nippon Denshoku Industries Co., Ltd.).
<< (1) Long-term whitening effect using a melanin-containing three-dimensional skin model in which normal human skin cells are layered and cultured >>
A melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 μg of evaluation cream is applied to the skin in each cup. The process of applying and washing out the cream every 2 days using the medium and applying 100 μg of the evaluation cream anew was repeated. Further, medium change every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, α-MSH, and β-FGF, trade names EPI-100LLM, MatTek) And cultured at 37 ° C. for 15 days.
On the 16th day, the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), and the L value was measured.
A melanin-containing three-dimensional skin model (trade name MEL-312-A, manufactured by MatTek, melanin-containing three-dimensional skin, Asian donor) is incubated at 37 ° C. for 15 hours, and then 100 μg of PBS is applied to the skin in each cup. Samples are replaced every two days, medium is replaced every day (serum-free medium, medium containing growth factors such as hEGF, hydrocortisone, gentamicin amphotericin B, α-MSH, and β-FGF) (Trade name EPI-100LLM, manufactured by MatTek) and cultured at 37 ° C. for 15 days.
On the 16th day, the skin was fixed using 10% by mass formalin dissolved in PBS (phosphate buffered saline), the L value was measured, and the ΔL value was calculated based on the following formula.
ΔL = (L value of cells coated with each sample−L value of cells coated with PBS used as a negative control)
From the obtained average value of ΔL, long-term whitening effect was evaluated according to the following evaluation criteria.
The average value of ΔL is preferably 20 or more, and more preferably 30 or more. If the average value of ΔL is less than 20, the long-term whitening effect may not be sufficient.
〔Evaluation criteria〕
◎: The average value of ΔL is 30 or more ○: The average value of ΔL is 20 or more and less than 30 Δ: The average value of ΔL is 10 or more and less than 20 ×: The average value of ΔL is less than 10
Lab値(L値が56~60、a値が8~10、b値が20~22)の男女専門パネラー20名(男性10名、女性10名、年齢20才~40才)に対し、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定した。そして、各皮膚化粧料0.5mLを手のひらに取り、顔に塗り広げる作業を1日1回ずつ1ヶ月間行った後、各自の顔を洗顔フォーム「植物物語」(ライオン株式会社製)1gで洗浄し、タオルドライした後5分間後に、Lab値を測定し、下記計算式に基づきΔE”を算出し、20名の専門パネラーのΔE”の平均値を求めた。
ΔE”=[{(塗布前のL値)-(1ヶ月後のL値)}2+{(塗布前のa値)-(1ヶ月後のa値)}2+{(塗布前のb値)-(1ヶ月後のb値)}2]1/2
求めたΔE”の平均値から、以下の評価基準により、長期的な美白効果について評価した。なお、前記ΔE”の平均値は、1.0以上が好ましく、2.0以上がより好ましい。前記ΔE”の平均値が、1.0未満であると、長期的な美白効果が十分ではないことがある。
〔評価基準〕
◎:ΔE”の平均値が2.0以上
○:ΔE”の平均値が1.0以上2.0未満
△:ΔE”の平均値が0.5以上1.0未満
×:ΔE”の平均値が0.5未満 << (2) Long-term whitening effect in humans >>
For 20 male and female panelists (10 males, 10 females, 20 to 40 years old) with Lab values (L value 56 to 60, a value 8 to 10, b value 20 to 22) The face was washed with 1 g of a face-washing form “Plant Monogatari” (manufactured by Lion Corporation), towel-dried, and after 5 minutes, the Lab value was measured. Then, after taking 0.5 ml of each skin cosmetic on the palm and spreading it on the face once a day for 1 month, each face was cleaned with 1 g of the face washing form “Plant Story” (manufactured by Lion Corporation). After 5 minutes after washing and towel drying, the Lab value was measured, ΔE ″ was calculated based on the following formula, and the average value of ΔE ″ of 20 professional panelists was obtained.
ΔE ″ = [{(L value before application) − (L value after one month)} 2 + {(a value before application) − (a value after one month)} 2 + {(b before application) Value) − (b value after one month)} 2 ] 1/2
From the obtained average value of ΔE ″, long-term whitening effect was evaluated according to the following evaluation criteria. The average value of ΔE ″ is preferably 1.0 or more, and more preferably 2.0 or more. If the average value of ΔE ″ is less than 1.0, the long-term whitening effect may not be sufficient.
〔Evaluation criteria〕
◎: The average value of ΔE ″ is 2.0 or more ○: The average value of ΔE ″ is 1.0 or more and less than 2.0 △: The average value of ΔE ″ is 0.5 or more and less than 1.0 ×: The average of ΔE ″ Value less than 0.5
*10:混合エキス(商品名プランテージEX、カンゾウ根エキスのエキス純分として0.5質量%、カワラヨモギエキスのエキス純分として0.047質量%、マグワ根皮エキスのエキス純分として0.035質量%、ナツメ果実エキスのエキス純分として0.063質量%、オウゴンエキスのエキス純分として0.045質量%、1,3-ブチレングリコール79.405質量%、及び水19.905質量%、丸善製薬株式会社製)
* 10: Mixed extract (trade name Plantage EX, 0.5% by mass as the extract of licorice root extract, 0.047% by mass as the extract of Kawaramugi extract, and 0.2% as the extract of mulberry root extract. 035% by weight, 0.063% by weight as a pure extract of jujube fruit extract, 0.045% by weight as a pure extract of ougon extract, 79.405% by weight of 1,3-butylene glycol, and 19.905% by weight of water Manufactured by Maruzen Pharmaceutical Co., Ltd.)
<1> (A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種を0.5質量%~15質量%、
(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
(D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
(E)アルピニアカツマダイ種子エキス、
を含有することを特徴とする皮膚化粧料である。
<2> 更に、(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスを含有する前記<1>に記載の皮膚化粧料である。
<3> (E)成分のアルピニアカツマダイ種子エキスの含有量が、エキス純分で、0.001質量%~0.01質量%である前記<1>から<2>のいずれかに記載の皮膚化粧料である。 Examples of the aspect of the present invention include the following.
<1> (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol,
(B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
(C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
(D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract,
It is a skin cosmetic characterized by containing.
<2> The skin cosmetic according to <1>, further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and urgonum extract.
<3> The content of the component (E) alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract, according to any one of <1> to <2> above It is a skin cosmetic.
Claims (3)
- (A)セチルアルコール、セトステアリルアルコール及びステアリルアルコールから選択される少なくとも1種を0.5質量%~15質量%、
(B)ステアリン酸及びステアリン酸カリウムの少なくともいずれかを0.5質量%~5質量%、
(C)酸化チタンで被覆されたマイカ及び酸化スズを含有する酸化チタンで被覆されたマイカの少なくともいずれかを0.5質量%~5質量%、
(D)水膨潤性粘土鉱物を0.1質量%~10質量%、並びに
(E)アルピニアカツマダイ種子エキス、
を含有することを特徴とする皮膚化粧料。 (A) 0.5 mass% to 15 mass% of at least one selected from cetyl alcohol, cetostearyl alcohol and stearyl alcohol;
(B) 0.5 mass% to 5 mass% of at least one of stearic acid and potassium stearate,
(C) 0.5% by mass to 5% by mass of at least one of mica coated with titanium oxide and mica coated with titanium oxide containing tin oxide,
(D) 0.1% by mass to 10% by mass of a water-swellable clay mineral, and (E) Alpinia katsudai seed extract,
A skin cosmetic characterized by comprising - 更に、(F)カンゾウ根エキス、カワラヨモギエキス、マグワ根皮エキス、ナツメ果実エキス、及びオウゴンエキスからなる混合エキスを含有する請求項1に記載の皮膚化粧料。 Furthermore, the skin cosmetic according to claim 1, further comprising (F) a mixed extract composed of licorice root extract, Kawara mugwort extract, mugwort bark extract, jujube fruit extract, and ougong extract.
- (E)成分のアルピニアカツマダイ種子エキスの含有量が、エキス純分で、0.001質量%~0.01質量%である請求項1から2のいずれかに記載の皮膚化粧料。 3. The skin cosmetic according to claim 1, wherein the content of the (E) component Alpinia katsudai seed extract is 0.001% by mass to 0.01% by mass in terms of pure extract.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015508438A JP6271517B2 (en) | 2013-03-29 | 2014-03-20 | Skin cosmetics |
PH12015502172A PH12015502172A1 (en) | 2013-03-29 | 2015-09-16 | Skin cosmetic |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013-073036 | 2013-03-29 | ||
JP2013073036 | 2013-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014157007A1 true WO2014157007A1 (en) | 2014-10-02 |
Family
ID=51623984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2014/057894 WO2014157007A1 (en) | 2013-03-29 | 2014-03-20 | Cosmetic preparation for skin |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6271517B2 (en) |
MY (1) | MY177862A (en) |
PH (1) | PH12015502172A1 (en) |
WO (1) | WO2014157007A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106966913A (en) * | 2017-04-06 | 2017-07-21 | 青岛科技大学 | A kind of preparation method of improved methacrylic acid dialkylamino ethyl ester |
JP2018172292A (en) * | 2017-03-31 | 2018-11-08 | 株式会社コーセー | Cosmetic or skin external preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001335499A (en) * | 2000-05-29 | 2001-12-04 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
JP2002179521A (en) * | 2000-12-13 | 2002-06-26 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of plant or animal |
JP2006290749A (en) * | 2005-04-06 | 2006-10-26 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor |
JP2007204379A (en) * | 2006-01-31 | 2007-08-16 | Ichimaru Pharcos Co Ltd | FORMULATION AND METHOD FOR ACTIVATING mTOR |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4970720B2 (en) * | 2003-12-15 | 2012-07-11 | 株式会社コーセー | Oil-in-water makeup cosmetics |
JP2005232088A (en) * | 2004-02-19 | 2005-09-02 | Kose Corp | Oil-in-water type cosmetic |
JP2008050271A (en) * | 2006-08-22 | 2008-03-06 | Shiseido Co Ltd | Makeup cosmetic |
JP2009242269A (en) * | 2008-03-31 | 2009-10-22 | Kose Corp | Oil-in-water type emulsion cosmetic |
-
2014
- 2014-03-20 MY MYPI2015703386A patent/MY177862A/en unknown
- 2014-03-20 WO PCT/JP2014/057894 patent/WO2014157007A1/en active Application Filing
- 2014-03-20 JP JP2015508438A patent/JP6271517B2/en active Active
-
2015
- 2015-09-16 PH PH12015502172A patent/PH12015502172A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001335499A (en) * | 2000-05-29 | 2001-12-04 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
JP2002179521A (en) * | 2000-12-13 | 2002-06-26 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of plant or animal |
JP2006290749A (en) * | 2005-04-06 | 2006-10-26 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor |
JP2007204379A (en) * | 2006-01-31 | 2007-08-16 | Ichimaru Pharcos Co Ltd | FORMULATION AND METHOD FOR ACTIVATING mTOR |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018172292A (en) * | 2017-03-31 | 2018-11-08 | 株式会社コーセー | Cosmetic or skin external preparation |
CN106966913A (en) * | 2017-04-06 | 2017-07-21 | 青岛科技大学 | A kind of preparation method of improved methacrylic acid dialkylamino ethyl ester |
Also Published As
Publication number | Publication date |
---|---|
PH12015502172A1 (en) | 2016-01-25 |
JP6271517B2 (en) | 2018-01-31 |
MY177862A (en) | 2020-09-23 |
JPWO2014157007A1 (en) | 2017-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1713433B1 (en) | Anti-wrinkle cosmetic | |
TW200520753A (en) | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | |
JP4091824B2 (en) | Skin preparation | |
KR101145060B1 (en) | O/W cosmetic composition having improved cosmetics formulation stability | |
CH700328B1 (en) | O / W emulsion for the care of the hand. | |
CN113576966B (en) | Composition for cosmetics, preparation method and application thereof | |
JP2003267822A (en) | Skin care preparation | |
JP4288306B2 (en) | Cosmetics containing dimer dilinoleic acid diethylene glycol oligomer ester | |
JP4548831B2 (en) | Hydrogenated retinoid or hydrogenated retinoid derivative and use thereof | |
JP6271517B2 (en) | Skin cosmetics | |
KR102463133B1 (en) | Cosmetic Composition Containing High-Content of Urea | |
JP2021098655A (en) | Skin external composition | |
JP4035481B2 (en) | Skin preparation | |
KR101462491B1 (en) | Cosmetic Compositions for Moisturizing Lips | |
DE10036051A1 (en) | Cosmetic or dermatological preparations for treating sun-tanning contain chitosan and lecithin to delay vaporization of volatile components | |
JP2001114635A (en) | Cosmetic composition containing extract of muscovado | |
JP6834084B2 (en) | Gentiana extract without gentiopicroside | |
JP5000964B2 (en) | Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression | |
JP5856761B2 (en) | External preparation for skin and method for producing the same | |
JP2009107984A (en) | Oily composition containing dimer dilinoleic acid diethylene glycol oligomer ester | |
DE102020202565A1 (en) | Improved preparation | |
JP3747192B2 (en) | Topical skin preparation | |
JP5144048B2 (en) | Radical scavenger, antioxidant skin external preparation, and radical scavenging method | |
JP2001199865A (en) | Bleaching cosmetic | |
FR3109886A1 (en) | Cosmetic composition comprising at least one calcareous red algae. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14775505 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2015508438 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12015502172 Country of ref document: PH |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: IDP00201506984 Country of ref document: ID |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14775505 Country of ref document: EP Kind code of ref document: A1 |